Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0002085929-26-000014·Bambusa Therapeutics, Inc.
Schedule 13G ownership disclosure
Bambusa Therapeutics, Inc.
Common Stock, par value $0.00001 per share · CUSIP: 058937103
Event date: 2026-10-29
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ATHOS KG
Shares: 4,579,067.00 · Class: 9.0%
- Objektgesellschaft Salzufer 1 GmbH
Shares: 4,579,067.00 · Class: 9.0%
- Salzufer Holding Inc.
Shares: 4,579,067.00 · Class: 9.0%
- Thomas Maier
Shares: 4,699,188.00 · Class: 9.2%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0002085929-26-000014
- Form type
- SCHEDULE 13G
- Filer
- Bambusa Therapeutics, Inc.
- CIK
- CIK 2044950
- Filed
- Nov 05, 2026
- Reporting period
- Oct 29, 2026
- Description
- Schedule 13G beneficial ownership